AI Transparency and the EU AI Act

Version 1.0, as of June 2026

This statement describes how Psynex uses artificial intelligence and how the platform relates to Regulation (EU) 2024/1689 (the AI Act, "EU AI Act"). It complements our Privacy Policy and our Terms of Service.

1. Classification of Psynex

Psynex is an AI-assisted tool for documentation and administration in psychotherapy. Psynex is not a medical device and not a high-risk AI system within the meaning of the AI Act. The platform assists with transcription, summarization and report generation. It does not make any diagnostic or therapeutic decisions.

2. Transparency (Art. 50 AI Act)

When using Psynex, it is apparent that artificial intelligence is being used. All content generated by the AI (transcripts, summaries, reports, phrasing suggestions) is provided solely as suggestions and is identified as AI-generated within the application.

3. Human Oversight and Final Responsibility

Every AI output is reviewed, edited and released by the treating professional. The professional and legal final responsibility for all documents lies with the therapist. No solely automated decision within the meaning of Art. 22 GDPR takes place.

4. AI Models Used

For AI processing, Psynex uses models from OpenAI via their EU infrastructure (EU Data Residency, Zero Data Retention). Entered content is not used to train AI models. Psynex is a deployer of these models within the meaning of the AI Act. The provider obligations for the underlying foundation model rest with OpenAI.

5. No Prohibited Practices

Psynex does not use any practices prohibited under Art. 5 AI Act. In particular, there is no social scoring, no biometric remote identification and no emotion recognition.

6. Marking of AI-Generated Content

Within the application it is apparent that the generated content originates from an AI. Psynex creates internal treatment documentation that is reviewed and released by the professional, and not content intended for publication to the public. We continuously monitor the technical requirements for machine-readable marking under Art. 50(2) AI Act, currently being specified through a Code of Practice of the EU Commission, and implement them to the extent that they apply to Psynex.

7. Limitations of AI

AI outputs can be incorrect or incomplete. Psynex does not replace the professional judgment, the duty of care or the therapeutic responsibility of the professional. All content must be reviewed before use.

8. Contact

For questions about our use of AI, please contact: info@psynex.de

Intermac systems, Sendnicher Str. 58a, 56072 Koblenz, Germany

As of June 2026, Version 1.0. This statement serves transparency purposes and does not constitute legal advice.

KI-Transparenz und EU-KI-Verordnung | Psynex | Psynex